Ibufarmalid (Ibuprofen)

Ibuprofen works by non‑selectively blocking the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which reduces the production of prostaglandins. Lower prostaglandin levels diminish inflammation, lessen pain signals, and reset the hypothalamic temperature set‑point, producing analgesic, antipyretic, and anti‑inflammatory effects.

The appropriate dose of Ibufarmalid is determined by the prescribing healthcare professional based on the patient’s condition, age, weight, and response. Dosage instructions should always follow the prescriber’s recommendation and the product label.

Safety of ibuprofen during pregnancy and lactation depends on the trimester and individual risk factors. It is generally avoided in the third trimester and should only be used in pregnancy or while breastfeeding if clearly indicated by a qualified healthcare provider.

To place an order, submit an enquiry on the Ibufarmalid product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ibufarmalid (ibuprofen) offers a balance of analgesic, antipyretic, and anti‑inflammatory activity with a relatively short half‑life, making it suitable for intermittent dosing. Compared with longer‑acting NSAIDs such as naproxen, ibuprofen may have a lower risk of prolonged gastrointestinal exposure but requires more frequent dosing for sustained effect.

Store Ibufarmalid at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiry date indicated on the label.

Ibufarmalid is intended for oral administration. The tablets (or other oral form) should be swallowed whole with a full glass of water, preferably with food or milk to reduce gastrointestinal irritation, unless otherwise directed by a healthcare professional.

Serious risks include gastrointestinal ulceration or bleeding, acute kidney injury, severe allergic reactions such as anaphylaxis, and cardiovascular events like heart attack or stroke, especially when used at high doses or for prolonged periods. Patients should seek immediate medical attention if they notice signs of these conditions.

Ibufarmalid should be avoided by individuals with known hypersensitivity to ibuprofen or other NSAIDs, those with active gastrointestinal bleeding, severe renal or hepatic impairment, and patients in the third trimester of pregnancy. It should also be used with caution in patients taking anticoagulants, certain antihypertensives, or other interacting medications.